348 related articles for article (PubMed ID: 25542988)
1. Formulation and characterization of inhalable magnetic nanocomposite microparticles (MnMs) for targeted pulmonary delivery via spray drying.
Stocke NA; Meenach SA; Arnold SM; Mansour HM; Hilt JZ
Int J Pharm; 2015 Feb; 479(2):320-8. PubMed ID: 25542988
[TBL] [Abstract][Full Text] [Related]
2. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.
Li X; Vogt FG; Hayes D; Mansour HM
J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):81-93. PubMed ID: 24502451
[TBL] [Abstract][Full Text] [Related]
3. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
Li X; Vogt FG; Hayes D; Mansour HM
J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
[TBL] [Abstract][Full Text] [Related]
4. Superparamagnetic iron oxide nanoparticles (SPIONs)-loaded Trojan microparticles for targeted aerosol delivery to the lung.
Tewes F; Ehrhardt C; Healy AM
Eur J Pharm Biopharm; 2014 Jan; 86(1):98-104. PubMed ID: 24055690
[TBL] [Abstract][Full Text] [Related]
5. Preparation and in vivo absorption evaluation of spray dried powders containing salmon calcitonin loaded chitosan nanoparticles for pulmonary delivery.
Sinsuebpol C; Chatchawalsaisin J; Kulvanich P
Drug Des Devel Ther; 2013; 7():861-73. PubMed ID: 24039397
[TBL] [Abstract][Full Text] [Related]
6. Development of an inhalable, stimuli-responsive particulate system for delivery to deep lung tissue.
Abbas Y; Azzazy HM; Tammam S; Lamprecht A; Ali ME; Schmidt A; Sollazzo S; Mathur S
Colloids Surf B Biointerfaces; 2016 Oct; 146():19-30. PubMed ID: 27244047
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary delivery of Nanocomposite Microparticles (NCMPs) incorporating miR-146a for treatment of COPD.
Mohamed A; Pekoz AY; Ross K; Hutcheon GA; Saleem IY
Int J Pharm; 2019 Oct; 569():118524. PubMed ID: 31319144
[TBL] [Abstract][Full Text] [Related]
8. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
[TBL] [Abstract][Full Text] [Related]
9. Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung.
Sham JO; Zhang Y; Finlay WH; Roa WH; Löbenberg R
Int J Pharm; 2004 Jan; 269(2):457-67. PubMed ID: 14706257
[TBL] [Abstract][Full Text] [Related]
10. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
Li X; Vogt FG; Hayes D; Mansour HM
Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
[TBL] [Abstract][Full Text] [Related]
11. Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: solid-state characterization and aerosol dispersion performance.
Ezzati Nazhad Dolatabadi J; Hamishehkar H; Valizadeh H
Drug Dev Ind Pharm; 2015; 41(9):1431-7. PubMed ID: 25220930
[TBL] [Abstract][Full Text] [Related]
12. Formulating Inhalable Dry Powders Using Two-Fluid and Three-Fluid Nozzle Spray Drying.
Leng D; Thanki K; Foged C; Yang M
Pharm Res; 2018 Nov; 35(12):247. PubMed ID: 30386927
[TBL] [Abstract][Full Text] [Related]
13. Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition.
Liao Q; Yip L; Chow MYT; Chow SF; Chan HK; Kwok PCL; Lam JKW
Int J Pharm; 2019 Apr; 560():144-154. PubMed ID: 30731259
[TBL] [Abstract][Full Text] [Related]
14. Preparation of honokiol-loaded chitosan microparticles via spray-drying method intended for pulmonary delivery.
Li X; Guo Q; Zheng X; Kong X; Shi S; Chen L; Zhao X; Wei Y; Qian Z
Drug Deliv; 2009 Apr; 16(3):160-6. PubMed ID: 19514976
[TBL] [Abstract][Full Text] [Related]
15. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension.
Shahin HI; Vinjamuri BP; Mahmoud AA; Shamma RN; Mansour SM; Ammar HO; Ghorab MM; Chougule MB; Chablani L
J Control Release; 2019 May; 302():126-139. PubMed ID: 30940497
[TBL] [Abstract][Full Text] [Related]
16. Rifampicin-Carbohydrate Spray-Dried Nanocomposite: A Futuristic Multiparticulate Platform For Pulmonary Delivery.
Mehanna MM; Mohyeldin SM; Elgindy NA
Int J Nanomedicine; 2019; 14():9089-9112. PubMed ID: 31819421
[TBL] [Abstract][Full Text] [Related]
17. Effect of particle size of dry powder mannitol on the lung deposition in healthy volunteers.
Glover W; Chan HK; Eberl S; Daviskas E; Verschuer J
Int J Pharm; 2008 Feb; 349(1-2):314-22. PubMed ID: 17904774
[TBL] [Abstract][Full Text] [Related]
18. Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers.
Acosta MF; Abrahamson MD; Encinas-Basurto D; Fineman JR; Black SM; Mansour HM
AAPS J; 2020 Nov; 23(1):2. PubMed ID: 33200330
[TBL] [Abstract][Full Text] [Related]
19. Conception, preparation and properties of functional carrier particles for pulmonary drug delivery.
Odziomek M; Sosnowski TR; Gradoń L
Int J Pharm; 2012 Aug; 433(1-2):51-9. PubMed ID: 22580211
[TBL] [Abstract][Full Text] [Related]
20. Dry powder inhaler formulation of high-payload antibiotic nanoparticle complex intended for bronchiectasis therapy: Spray drying versus spray freeze drying preparation.
Yu H; Teo J; Chew JW; Hadinoto K
Int J Pharm; 2016 Feb; 499(1-2):38-46. PubMed ID: 26757148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
